Analysis of 123 primary melanomas with both in situ and invasive components revealed similar Cks1 expression in both components in 65 cases, higher Cks1 expression of in situ component in 38 cases and higher Cks1 expression in invasive component in 20 cases. This evidence concerns the gene CKS1B and melanoma.